Credit Suisse Ag Illumina, Inc. Call Options Transaction History

Credit Suisse Ag

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $7.06 Million - $9.13 Million	-17,400 Reduced 64.68%	9,500 $3.85 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $5.59 Million - $7.22 Million	-15,000 Reduced 35.8%	26,900 $12.7 Million
Q1 2021 May 14, 2021	SELL	$361.28 - $504.76 $10.9 Million - $15.3 Million	-30,300 Reduced 41.97%	41,900 $16.1 Million
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $1.46 Million - $1.85 Million	-5,000 Reduced 6.48%	72,200 $26.7 Million
Q3 2020 Nov 13, 2020	SELL	$268.51 - $400.74 $9.59 Million - $14.3 Million	-35,700 Reduced 31.62%	77,200 $23.9 Million
Q2 2020 Aug 12, 2020	BUY	$256.46 - $373.01 $16.2 Million - $23.6 Million	63,200 Added 127.16%	112,900 $41.8 Million
Q1 2020 May 13, 2020	BUY	$209.2 - $335.53 $3.41 Million - $5.47 Million	16,300 Added 48.8%	49,700 $13.6 Million
Q4 2019 Feb 12, 2020	BUY	$288.29 - $335.49 $1.07 Million - $1.24 Million	3,700 Added 12.46%	33,400 $11.1 Million
Q3 2019 Nov 12, 2019	BUY	$266.84 - $378.23 $2.56 Million - $3.63 Million	9,600 Added 47.76%	29,700 $9.04 Million
Q2 2019 Aug 14, 2019	BUY	$300.59 - $368.15 $6.04 Million - $7.4 Million	20,100 New	20,100 $7.4 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.